The reduced expression of TMPRSS2 in SARS‐CoV‐infected cells hints at the potential susceptibility of tumor tissues in COVID‐19 patients with PCa to SARS‐CoV‐2 infection, which may worsen prognosis. The gene discussed is TMPRSS2; the disease is COVID-19.